Management of breakthrough seizures in the emergency department: continuity of patient care

References

• Sheth RD. Adolescent issues in epilepsy. J Child Neurol 2002;17\(Suppl 2):2S23–2S7
   Google Scholar
• Bureau USC. 2006. Data finders: population clocks. Available from http://www.census.gov [last accessed 5 September 2006]
   Google Scholar
• Shinnar S, Berg AT. Does antiepileptic drug therapy prevent the development of ‘chronic’ epilepsy? Epilepsia 1996;37: 701–8
   PubMed Web of Science ®Google Scholar
• Nadkarni S, LaJoie J, Devinsky O. Current treatments of epilepsy. Neurology 2005;64:S2–S11
   Google Scholar
• Kripalani S, LeFevre F, Phillips CO, et al. Deficits in communication and information transfer between hospital-based and primary care physicians: implications for patient safety and continuity of care. J Am Med Assoc 2007;297:831–41
   PubMed Web of Science ®Google Scholar
• Kyriacou DN, Handel D, Stein AC, et al. BRIEF REPORT: factors affecting outpatient follow-up compliance of emergency department patients. J Gen Intern Med 2005;20:938–42
   PubMed Web of Science ®Google Scholar
• Kanner AM, Balabanov AJ. The use of monotherapy in patients with epilepsy: an appraisal of the new antiepileptic drugs. Curr Neurol Neurosci Rep 2005;5:322–8
   PubMedGoogle Scholar
• Bergey G. Initial treatment of epilepsy: special issues in treating the elderly. Neurology 2004;63:S40–S48
   Google Scholar
• Sander JW. The use of antiepileptic drugs – principles and practice. Epilepsia 2004;45(Suppl 6):28–34
   PubMed Web of Science ®Google Scholar
• McCraig L, Nawar E. National hospital ambulatory medical care survey: 2004 emergency department summary. In: Advance data from vital and health statistics. Atlanta: Centers for Disease Control and Prevention, Health and Human Services; 2006. p. 1–30
   Google Scholar
• Garnet WR. Antiepileptic drug treatment: outcomes and adherence. Pharmacotherapy 2000;20:191S–199S
   Google Scholar
• Carpay JA, Aldenkamp AP, van Donselaar CA. Complaints associated with the use of antiepileptic drugs: results from a community-based study. Seizure 2005;14:198–206
   Google Scholar
• Marks Jr WJ, Garcia PA. Management of seizures and epilepsy. Am Fam Physician 1998;57:1589–600, 603–4
   Google Scholar
• Carter BL, Garnett WR, Pellock JM, et al. Effect of antacids on phenytoin bioavailability. Ther Drug Monit 1981;3:333–40
   PubMed Web of Science ®Google Scholar
• Donner EJ, Snead 3rd OC. New generation anticonvulsants for the treatment of epilepsy in children. NeuroRx 2006;3:170–80
   Google Scholar
• Dickinson RG, Hooper WD, Patterson M, et al. Extent of urinary excretion of p-hydroxyphenytoin in healthy subjects given phenytoin. Ther Drug Monit 1985;7:283–9
   PubMed Web of Science ®Google Scholar
• Fritz S, Lindner W, Roots I, et al. Stereochemistry of aromatic phenytoin hydroxylation in various drug hydroxylation pheno-types in humans. J Pharmacol Exp Ther 1987;241:615–22
   PubMed Web of Science ®Google Scholar
• Gates JR. Using new antiepileptic drugs as monotherapy. Curr Treat Options Neurol 2004;6:223–30
   PubMedGoogle Scholar
• Engel Jr J, Starkman S. Overview of seizures. Emerg Med Clin North Am 1994;12:895–923
   PubMedGoogle Scholar
• Guidance for industry: bioavailability and bioequivalence studies for orally administered drug products. General considerations. Available from http://www.fda.gov/cder/guidance/5356fnl.htm [last accessed 31 October 2006]
   Google Scholar
• Benbadis SR. Practical management issues for idiopathic generalized epilepsies. Epilepsia 2005;46(Suppl 9):125–32
   PubMedGoogle Scholar
• Bergey G. Evidence-based treatment of idiopathic generalized epilepsies with new antiepileptic drugs. Epilepsia 2005;46: 161–8
   PubMed Web of Science ®Google Scholar
• Herman ST. Single unprovoked seizures. Curr Treat Options Neurol 2004;6:243–55
   PubMedGoogle Scholar
• NICE. Quick reference guide. The epilepsies: diagnosis and management of the epilepsies in adults in primary and secondary care. Clinical Guideline 20, 2004, 73pp
   Google Scholar
• Theodore W. Is epilepsy a progressive disease? Eur J Clin Res 2003;9:2
   Google Scholar
• Nordli Jr DR. Special needs of the adolescent with epilepsy. Epilepsia 2001;42(Suppl 8):10–7
   Google Scholar
• Roth HL, Drislane FW. Seizures. Neurol Clin 1998;16:257–84
   PubMed Web of Science ®Google Scholar
• French JA. Catamenial epilepsy: the elusive condition. Epilepsy Curr 2005;5:113–4
   PubMedGoogle Scholar
• Pennell PB. Antiepileptic drug pharmacokinetics during pregnancy and lactation. Neurology 2003;61:S35–S42
   PubMed Web of Science ®Google Scholar
• Anon. Clinical policy: critical issues in the evaluation and management of adult patients presenting to the emergency department with seizures. Ann Emerg Med 2004;43:605–25
   PubMed Web of Science ®Google Scholar
• Theodore WH, Porter RJ, Albert P, et al. The secondarily generalized tonic–clonic seizure: a videotape analysis. Neurology 1994;44:1403–7
   PubMed Web of Science ®Google Scholar
• Eisner RF, Turnbull TL, Howes DS, et al. Efficacy of a ‘standard’ seizure workup in the emergency department. Ann Emerg Med 1986;15:33–9
   PubMed Web of Science ®Google Scholar
• Sempere AP, Villaverde FJ, Martinez-Menendez B, et al. First seizure in adults: a prospective study from the emergency department. Acta Neurol Scand 1992;86:134–8
   Google Scholar
• Kozer E, Scolnik D, Agamata WM, et al. Utility of antiepileptic drug monitoring in the pediatric emergency department. Ther Drug Monit 2003;25:17–21
   PubMed Web of Science ®Google Scholar
• Krumholz A, Grufferman S, Orr ST, et al. Seizures and seizure care in an emergency department. Epilepsia 1989;30:175–81
   PubMed Web of Science ®Google Scholar
• Karceski S, Morrell M, Carpenter D. Treatment of epilepsy in adults: expert opinion, 2005. Epilepsy Behav 2005;7:S1–S64
   Google Scholar
• Bazil MK, Bazil CW. Recent advances in the pharmacotherapy of epilepsy. Clin Ther 1997;19:369–82 [discussion 7–8]
   Google Scholar
• French JA, Kanner AM, Bautista J, et al. Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 2004;62:1252–60
   PubMed Web of Science ®Google Scholar
• Beghi E. Efficacy and tolerability of the new antiepileptic drugs: comparison of two recent guidelines. Lancet Neurol 2004;3:618–21
   PubMed Web of Science ®Google Scholar
• Sheth RD. Metabolic concerns associated with antiepileptic medications. Neurology 2004;63:S24–S940
   Google Scholar
• LYRICA [product insert]. New York, NY: Pfizer Inc
   Google Scholar
• European Medicines Agency. Committee for medicinal products for human use post-authorisation summary of positive opinion for Keppra Doc. Ref. EMEA/CHMP/455195/2006
   Google Scholar
• TRILEPTAL [product insert]. East Hanover, NJ: Novartis Pharmaceuticals Corp
   Google Scholar
• TOPAMAX [product insert]. Titusville, NJ: Ortho-McNeil Neurologics, Inc
   Google Scholar
• NEURONTIN [product insert]. New York, NY: Pfizer Inc
   Google Scholar
• LAMICTAL [product insert]. Research Triangle Park, NC: GlaxoSmithKline
   Google Scholar
• GABITRIL [product insert]. West Chester, PA: Cephalon, Inc
   Google Scholar
• FELBATOL [product insert]. Somerset, NJ: MedPoint Pharmaceuticals
   Google Scholar
• DEPACON [product insert]. North Chicago, Illinois: Abbott Laboratories
   Google Scholar
• CEREBYX [product insert]. Teaneck, NJ: Eisai Inc
   Google Scholar
• KEPPRA [product insert]. Smyrna, Georgia: UCB, Inc
   Google Scholar
• ZONEGRAN [product insert]. Teaneck, NJ: Eisai Inc
   Google Scholar